The pharmacology of psilocybin

  title={The pharmacology of psilocybin},
  author={T. Passie and J. Seifert and U. Schneider and H. Emrich},
  journal={Addiction Biology},
  • T. Passie, J. Seifert, +1 author H. Emrich
  • Published 2002
  • Medicine, Psychology
  • Addiction Biology
  • Psilocybin (4‐phosphoryloxy‐N,N‐dimethyltryptamine) is the major psychoactive alkaloid of some species of mushrooms distributed worldwide.These mushrooms represent a growing problem regarding hallucinogenic drug abuse. Despite its experimental medical use in the 1960s, only very few pharmacological data about psilocybin were known until recently. Because of its still growing capacity for abuse and the widely dispersed data this review presents all the available pharmacological data about… CONTINUE READING
    Metabolism of psilocybin and psilocin: clinical and forensic toxicological relevance
    • 25
    • PDF
    Toxicity of amphetamines: an update
    • 242
    Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer.
    • 433
    • PDF


    Publications referenced by this paper.
    Comparison of psilocin with psilocybin, mescaline and LSD-25
    • 53
    Comparison of the reactions induced by psilocybin and LSD-25 in man
    • 62
    Serotonin-dopamine interaction and its relevance to schizophrenia.
    • 776
    Differential interactions of indolealkylamines with 5-hydroxytryptamine receptor subtypes
    • 115